TransCode TherapeuticsOffering
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
Rod Turner's blog Reg A+ offerings- Anyone can invest CalTier ... + offering, the Convertible Notes will be converted into Reg A+ shares at a ... non-opiate, non-addictive painkiller. The InSitu Biologics offer is closing soon. Minimum ...
addresses what security expert Dan Geer referred to in his 2015 RSA keynote ... firewalls using decade-old Linux kernels, while the consumer firewall market ... followed by what Ayoub stated was another few thousand from the two to three ...
is offering VOX tokens to power the Talketh smartphone application. Leveraging ... service that can be used from New York to Nairobi. Powered by Globex's ... offering size $ 35,000,000 Valuation $ OFFERING Price $ 1.00 ...
RodTurner's blog Reg A+ offerings- Anyone can invest ... into the animal market with their new AniGel™ Product The offering is closing on November 30, 2019 Check out InSitu Exclusive offerings only for Accredited ...
vehicles, utilizing the private placement REG “D” offering exemptions. Ross ... $7.75 million raised, offering completed September 2017 $10,000 Minimum ... seeking a double digit return over a shorter period of time. This Offering ...
Service providers for the ShiftPixie Reg A+ IPO: FundAmerica (transaction technology), Prime Trust (escrow), and Vstock Transfe r (registered transfer agent). ...
Offering Completed - Earn an annual dividend of 8%, paid monthly. $500 minimum investment
Costs For Reg D and Reg A+ STOs; Legal fee $12k- $50k depending on complexity. (Reg A+ is at least $40k). Reg D and Reg S are less. Marketing fee ... (The Reg D fee includes AML check and accreditation verification) see our ...
class and remain engaged. Levy’s advice is different than what many ... to raise capital using Regulation A+. Turner has played a key role ...